Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | PREP | P48147 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.44 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | VCP | P55072 | 1/20 | 0.44 |
| ▸ | ME3 | Q16798 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22552563 | 1.00 | ITGB3 (0.48) | ITGB3ITGA2BLMNASMN1; SMN2MAPK1 | |
| SCHEMBL28418424 | 0.91 | POLB (0.49) | ITGB3ITGA2BLMNASMN1; SMN2MAPK1 | |
| SCHEMBL28418425 | 0.91 | POLB (0.49) | ITGB3ITGA2BLMNASMN1; SMN2MAPK1 | |
| SCHEMBL2163641 | 0.87 | CTRB1 (0.52) | LMNASMN1; SMN2ALDH1A1CYP1A2DPP4 | |
| SCHEMBL1440328 | 0.87 | CTRB1 (0.52) | LMNASMN1; SMN2ALDH1A1CYP1A2DPP4 | |
| SCHEMBL7337637 | 0.85 | ALDH1A1 (0.52) | ALDH1A1CYP1A2DPP4KCNH2DPP7 | |
| SCHEMBL7810127 | 0.85 | ALDH1A1 (0.54) | ALDH1A1CYP1A2DPP4KCNH2DPP7 | |
| SCHEMBL7333566 | 0.85 | ALDH1A1 (0.54) | ALDH1A1CYP1A2DPP4KCNH2DPP7 | |
| SCHEMBL1162837 | 0.84 | CTSK (0.49) | ITGB3ITGA2BLMNAALDH1A1CYP1A2 | |
| SCHEMBL3374501 | 0.84 | CTSK (0.49) | ITGB3ITGA2BLMNAALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11279735-B2 | Cyclic peptide antibiotics | GENENTECH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-20200331968-A1 | CYCLIC PEPTIDE ANTIBIOTICS | GENENTECH, INC. (US) | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331968-A1 | CYCLIC PEPTIDE ANTIBIOTICS | NPPA, LNPEP, CLPP | ITGB3 4794/4885ITGA2B 4338/4885LMNA 637/4885 |
| US-11279735-B2 | Cyclic peptide antibiotics | NPPA, LNPEP, CLPP | ITGB3 4794/4885ITGA2B 4338/4885LMNA 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.